コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ) progression, implicating mechanisms beyond renal clearance.
2 y dipeptidyl peptidase-4 (DPP-4) and through renal clearance.
3 l imaging may increase the size too much for renal clearance.
4 ted fast in vivo pharmacokinetics with major renal clearance.
5 albumin-binding peptide to prevent its rapid renal clearance.
6 s a dangling carboxylate to facilitate rapid renal clearance.
7 er limit of 5-10 ligands per quantum dot for renal clearance.
8 escriptors show a positive relationship with renal clearance.
9 nd to be the physicochemical determinants of renal clearance.
10 utic plasma levels of drugs with predominant renal clearance.
11 nother serum protein that protects RBP4 from renal clearance.
12 rse cholesterol transport or, alternatively, renal clearance.
13 a-BBN(7-14) exhibited both hepatobiliary and renal clearance.
14 ropriate prescribing, in view of compromised renal clearance.
15 by its short biological half-life and rapid renal clearance.
16 onsidered when measuring Hcy plasma flux and renal clearance.
17 dney and liver uptake with equal biliary and renal clearance.
18 atively high kidney uptake and predominantly renal clearance.
19 (PF-4) and a lysine-rich sequence for rapid renal clearance.
20 axel using a dose formula based on projected renal clearance.
21 llular distribution with predominantly rapid renal clearance.
22 hich was improved by a targeted reduction in renal clearance.
23 tumour retention, insignificant toxicity and renal clearance.
24 the PDC in receptor-positive tumors and high renal clearance.
25 d signal enhancement in the kidneys and fast renal clearance.
26 Biodistribution showed fast renal clearance.
27 etic properties, good tumor penetration, and renal clearance.
28 0.5 - 1 hour postinjection followed by rapid renal clearance.
29 ide, however, was rapidly eliminated through renal clearance.
30 difications, peptides are rapidly removed by renal clearance.
31 ction site to peripheral tissues by reducing renal clearance.
32 n protects against enzymatic degradation and renal clearance.
33 th that of two existing models for augmented renal clearance.
34 es (carboxylates) on the chelator, promoting renal clearance.
35 esult from increased formation and decreased renal clearance.
36 tion by dipeptidyl peptidase-IV (DPP-IV) and renal clearance.
37 tion by dipeptidyl peptidase-IV (DPP-IV) and renal clearance.
38 al accumulation in normal tissues, and rapid renal clearance.
39 ave low kidney retention and relatively fast renal clearance.
40 ed the highest tumor accumulation and little renal clearance.
41 all tracers, and they all showed predominant renal clearance.
42 le gastrointestinal absorption and nonlinear renal clearance act additively to produce the ceiling ef
43 robe showed selective tumor uptake and rapid renal clearance, affirming that the pepa-pic(2) chelator
45 was also found in vivo, with a predominantly renal clearance and a specific uptake in the PD-L1-overe
47 can be valuable in early prediction of human renal clearance and can aid the chemist in structural mo
48 8)Ga-PNT6555 and (68)Ga-PNT6952 showed rapid renal clearance and continuous accumulation in tumors, r
50 predicts that a GCSF analog that eliminates renal clearance and has reduced endosomal binding affini
52 labeled C2Am derivative showed predominantly renal clearance and high specificity and sensitivity for
53 biodistribution profiles, with predominantly renal clearance and low nonspecific retention in the liv
54 n mouse blood for 5 h and demonstrated rapid renal clearance and lower blood levels in vivo compared
57 d antibody recycling, thereby evading ligand renal clearance and requiring increasingly high antibody
58 ulant activity; however, problems with rapid renal clearance and short circulation half-life have pre
60 mathematical modeling successfully predicted renal clearance and systemic disposition of opioids in C
62 rating near infrared emission with efficient renal clearance and ultralow background interference, th
63 Evaluation in vivo demonstrated primarily renal clearance and uptake of approximately 8 percentage
65 s reduction may be attributable to defective renal clearance and/or extrarenal clearance and metaboli
66 in vivo by reducing nuclease hydrolysis and renal clearance, and achieved high and sustained inhibit
68 mor uptake and high retention, predominantly renal clearance, and fast wash-out from blood and other
70 ion of myocardial radioactivity, substantial renal clearance, and high metabolic stability in plasma.
72 ity to degradation in the circulation, rapid renal clearance, and immunostimulatory adverse effects g
73 CKD and determined by intestinal uptake and renal clearance, and it is not fully accounted for by di
74 aled rapid and persistent tumor uptake, fast renal clearance, and low retention in normal tissues.
75 e bloodstream with a 5.7 min half-life, high renal clearance, and low, transient liver enhancement in
78 (IRDye 800CW) in physiological stability and renal clearance but exhibit a much longer tumor retentio
80 irculation half-life of 5.6 h and to undergo renal clearance-characteristics needed for nanomedicines
81 methods that provide accurate prediction of renal clearance (CL(r)) and systemic disposition of opio
82 showed 64Cu-DOTA-knottin 2.5F to have a fast renal clearance combined with low nonspecific accumulati
83 in chronic kidney disease because decreased renal clearance contributes to cardiovascular and liver
84 ibutions were also assayed in the absence of renal clearance (e.g., in mice rendered surgically aneph
86 ze result in four- to ninefold reductions in renal clearance efficiency in the early elimination stag
87 y but different densities, we found that the renal-clearance efficiency exponentially increased in th
88 h solute/regimen combination, the equivalent renal clearance (EKR: ml/min) was calculated as a dimens
89 lysis and hemodialysis? (2) Are dialytic and renal clearances equivalent? and (3) Will survival impro
90 odified Brenner method, in which (99m)Tc-MDP renal clearance estimated from the whole-body counts was
94 ion, urinary fluoride excretion and fluoride renal clearance following no exercise and three exercise
95 of physicochemical properties and the human renal clearance for a data set of 391 drugs or compounds
97 c residues with smaller dimensions to ensure renal clearance for better biocompatibility of the funct
98 e daily or valganciclovir (dose-adjusted for renal clearance) for 8 weeks with 12 weeks of follow-up.
99 y large size, can be efficiently excreted by renal clearance from the host after systemic injection.
101 en the scFv were evaluated in the absence of renal clearance in anephric mice, indicating that the ra
102 y the deleterious systemic effects of absent renal clearance in ARF without the confounding effects t
107 d pharmaceuticals in patients with augmented renal clearance, in addition to the potential impact on
108 y, increased blood circulation time, reduced renal clearance, increased tumor biodistribution, and gr
110 ghtly longer than that of ShK, implying that renal clearance is the major determinant of its plasma l
113 ent was subtracted from the total (bone plus renal) clearance (K(total)) measured from the free (99m)
114 iopharmaceuticals; however, both agents have renal clearances less than that of (131)I-orthoiodohippu
115 all excellent renal imaging agents but have renal clearances lower than that of (131)I-orthoiodohipp
118 plasma half-life was 27.3 min with primarily renal clearance (mean 25.7% +/- 5.4% of injected dose 4
122 a-pic(2) as the lead scaffold, showing rapid renal clearance, minimal nontarget retention, and high i
123 ands and small bowel, with hepatobiliary and renal clearance noted, whereas (68)Ga-RM2 had the highes
126 metformin PET/CT in 6 anesthetized pigs, and renal clearance of (11)C-metformin was compared with ren
129 earance of (11)C-metformin was compared with renal clearance of (51)Cr-ethylenediaminetetraacetic aci
135 modal imaging studies in mice to investigate renal clearance of a single-walled carbon nanotube (SWCN
138 he blood retention, kidney accumulation, and renal clearance of Au25(SG)18 in a doxorubicin-induced a
140 her transplacental transfer efficiencies and renal clearance of branched PFOS and PFOA isomers, compa
145 'bandpass' filter to significantly slow down renal clearance of few-atom gold nanoclusters (AuNCs) wi
146 We used microperfusion, micropuncture, and renal clearance of FITC-inulin to examine the effects of
147 he indocyanine-green or both, methods and by renal clearance of inulin and para-aminohippurate (PAH),
149 e, were examined against GFR measured by the renal clearance of iothalamate in 1286 individuals with
150 on exchange (ionic etching), and facilitates renal clearance of metal ions released from the quantum
152 can be employed to evaluate the mechanism of renal clearance of organic anions, to assess potential d
161 34 hemodialysis patients (with no meaningful renal clearance of sodium), and 31 patients with chronic
164 rasmall size of Cu(5.4)O USNPs enables rapid renal clearance of the nanomaterial, guaranteeing the bi
166 in anephric mice, indicating that the rapid renal clearance of the scFv was not responsible for thes
168 r of QD-Cys ( approximately 6 nm) allows for renal clearance of these nanoparticles in rat models.
169 modifier to improve the water solubility and renal clearance of three hydrophilic analogues of 1.
172 ive, better tolerated agents to increase the renal clearance of uric acid and thereby control hyperur
175 Out of 33,258 ICU days, we found augmented renal clearance on 19.6% of all ICU days in the developm
179 xed-effects model, the presence of augmented renal clearance on study day 1 strongly predicted (p = 0
181 r, a clinical prediction model for augmented renal clearance on the next day during ICU stay, and mad
182 ht (6.8 kDa) of the ProGel-Dex ensures rapid renal clearance once it escapes the joint, limiting syst
183 that predonation GFR as measured by isotopic renal clearance or any of the creatinine-based estimatio
184 d by several drug delivery hurdles including renal clearance, phagocytosis, enzymatic degradation, pr
185 We developed and validated our augmented renal clearance predictor, a clinical prediction model f
186 ined six clinical variables in our augmented renal clearance predictor: day from ICU admission, age,
187 ficantly to its enhanced tumor-targeting and renal clearance properties and makes DOTAReCCMSH an exce
188 etection that leverages the fluorescence and renal clearance properties of carbon quantum dots (CQDs)
191 embrane-water distribution coefficients, and renal clearance rate are among the most important model
195 es demonstrated conjugate safety profile and renal clearance route of the selected PGA-doxy candidate
196 antly decreased from A to V, consistent with renal clearance, several were found to increase, the mos
197 h a modification that effectively eliminates renal clearance should have a significantly longer half-
198 3-fold, tumor retention of CGT prolonged and renal clearance significantly reduced when compared with
201 A range of techniques were used including renal clearance studies, in situ microperfusion, RT-PCR
203 (95% CI, 1.23-1.71) adjustment when relating renal clearance to creatinine-based estimated glomerular
204 studies, immunoblotting, immunostaining, and renal clearance to examine Kir4.1/Kir5.1 activity in the
206 and 36(17) mug/h; and iii) rate of fluoride renal clearance was 26.5(9.0), 27.2(30.4), 13.1(20.4) an
210 safe systemic administration and systematic renal clearance was demonstrated in both tested species.
212 oxaban, an oral factor Xa inhibitor with 50% renal clearance, was noninferior to well-managed warfari
214 stance to degradation and presumably reduced renal clearance were obtained by introducing a 1,4-disub
215 ntracerebral hemorrhage experienced enhanced renal clearance, which may be otherwise unknown to clini
216 egree of functionalization on MWNTs enhanced renal clearance, while lower functionalization promoted
217 tudies in the Fabry mouse model showed quick renal clearance with high radioactive uptake in the hear
218 oncentration and decline in rate of fluoride renal clearance with increasing exercise intensity needs
219 biodistribution study showed rapid blood and renal clearance with low retention in all major organs a
220 aqueous and organic solvents, thus improving renal clearance with minimal binding to serum proteins d
221 t decline in urinary carnitine excretion and renal clearance with nonesterfied carnitine (NEC) declin
222 a blood half-life of 25.8 +/- 4.6 min, rapid renal clearance with only 26.2 +/- 6.1 percentage inject